Maru SY, Jaffee EM. Pancreatic cancer is feeling the heat. J Immunother Cancer. 2024;12(10):e010124.
Bryce C, Bucaj M. Pancreatic cancer: rapid evidence review. Am Family Phys. 2024;109(3):245–50.
Martin RF. Management of pancreatic cancer. Surg Clin North Am. 2024;104(5):xiii–xv.
Jinno N, Yoshida M, Hayashi K, Naitoh I, Hori Y, Natsume M, Kato A, Kachi K, Asano G, Atsuta N, et al. Autotaxin in Ascites promotes peritoneal dissemination in pancreatic cancer. Cancer Sci. 2021;112(2):668–78.
Article CAS PubMed Google Scholar
Gravallese EM, Firestein GS, Koscal N, Ling E, Longo DL, Messenger LA, Schubach A. What is rheumatoid arthritis? N Engl J Med. 2024;390(13):e32.
Zhang F, Jonsson AH, Nathan A, Millard N, Curtis M, Xiao Q, Gutierrez-Arcelus M, Apruzzese W, Watts GFM, Weisenfeld D, et al. Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes. Nature. 2023;623(7987):616–24.
Article CAS PubMed PubMed Central Google Scholar
Wu X, Peng H, Wen Y, Cai X, Li C, Zhong R, Huang Y, Chen J, Huo Z, Wang R, et al. Rheumatoid arthritis and risk of lung cancer: Meta-analysis and Mendelian randomization study. Semin Arthritis Rheum. 2021;51(3):565–75.
Article CAS PubMed Google Scholar
Simon TA, Thompson A, Gandhi KK, Hochberg MC, Suissa S. Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Therapy. 2015;17(1):212.
Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, et al. Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis. 2005;64(10):1414–20.
Article CAS PubMed PubMed Central Google Scholar
Yuan S, Carter P, Bruzelius M, Vithayathil M, Kar S, Mason AM, Lin A, Burgess S, Larsson SC. Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study. EBioMedicine. 2020;59:102956.
Article CAS PubMed PubMed Central Google Scholar
Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet. 2014;23(R1):R89–98.
Article CAS PubMed PubMed Central Google Scholar
Burgess S, Small DS, Thompson SG. A review of instrumental variable estimators for Mendelian randomization. Stat Methods Med Res. 2017;26(5):2333–55.
Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, VanderWeele TJ, Higgins JPT, Timpson NJ, Dimou N, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326(16):1614–21.
Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, Davey Smith G, Sterne JA. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21(3):223–42.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent Estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304–14.
Article PubMed PubMed Central Google Scholar
Yuan S, Chen J, Ruan X, Vithayathil M, Kar S, Li X, Mason AM, Burgess S, Larsson SC. Rheumatoid arthritis and risk of site-specific cancers: Mendelian randomization study in European and East Asian populations. Arthritis Res Therapy. 2022;24(1):270.
Hashimoto A, Chiba N, Tsuno H, Komiya A, Furukawa H, Matsui T, Nishino J, Tohma S. Incidence of malignancy and the risk of lymphoma in Japanese patients with rheumatoid arthritis compared to the general population. J Rhuematol. 2015;42(4):564–71.
Adebayo M, Singh S, Singh AP, Dasgupta S. Mitochondrial fusion and fission: the fine-tune balance for cellular homeostasis. Faseb J. 2021;35(6):e21620.
Article CAS PubMed Google Scholar
Yan C, Shi Y, Yuan L, Lv D, Sun B, Wang J, Liu X, An F. Mitochondrial quality control and its role in osteoporosis. Front Endocrinol. 2023;14:1077058.
Cui L, Weiyao J, Chenghong S, Limei L, Xinghua Z, Bo Y, Xiaozheng D, Haidong W. Rheumatoid arthritis and mitochondrial homeostasis: the crossroads of metabolism and immunity. Front Med. 2022;9:1017650.
An HJ, Ryu M, Jeong HJ, Kang M, Jeon HM, Lee JO, Kim YS, Lee H. Higd-1a regulates the proliferation of pancreatic cancer cells through a pERK/p27(KIP1)/pRB pathway. Cancer Lett. 2019;461:78–89.
Article CAS PubMed Google Scholar
Courtois S, de Luxán-Delgado B, Penin-Peyta L, Royo-García A, Parejo-Alonso B, Jagust P, Alcalá S, Rubiolo JA, Sánchez L, Sainz B, editors. Jr. Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential. Cancers (Basel). 2021;13(4).
Bishop EL, Gudgeon N, Fulton-Ward T, Stavrou V, Roberts J, Boufersaoui A, Tennant DA, Hewison M, Raza K, Dimeloe S. TNF-α signals through ITK-Akt-mTOR to drive CD4(+) T cell metabolic reprogramming, which is dysregulated in rheumatoid arthritis. Sci Signal. 2024;17(833):eadg5678.
Article CAS PubMed Google Scholar
Chumak V, Rajacharya GH, Singh PK. Metabolomic investigations into Hypoxia-Mediated metabolic reprogramming of pancreatic cancer cells. Methods Mol Biology (Clifton NJ). 2024;2755:191–200.
Willemsen J, Neuhoff MT, Hoyler T, Noir E, Tessier C, Sarret S, Thorsen TN, Littlewood-Evans A, Zhang J, Hasan M, et al. TNF leads to MtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis. Cell Rep. 2021;37(6):109977.
Article CAS PubMed Google Scholar
Schwörer S, Cimino FV, Ros M, Tsanov KM, Ng C, Lowe SW, Carmona-Fontaine C, Thompson CB. Hypoxia potentiates the inflammatory fibroblast phenotype promoted by pancreatic cancer Cell-Derived cytokines. Cancer Res. 2023;83(10):1596–610.
Article PubMed PubMed Central Google Scholar
Yu D, Du J, Pu X, Zheng L, Chen S, Wang N, Li J, Chen S, Pan S, Shen B. The gut Microbiome and metabolites are altered and interrelated in patients with rheumatoid arthritis. Front Cell Infect Microbiol. 2021;11:763507.
Article CAS PubMed Google Scholar
Papa V, Schepis T, Coppola G, Chiappetta MF, Del Vecchio LE, Rozera T, Quero G, Gasbarrini A, Alfieri S, Papa A. The role of microbiota in pancreatic cancer. Cancers (Basel). 2023;15(12):3143.
Zhang Y, Zhang H, Liu B, Ning K. Highly accurate diagnosis of pancreatic cancer by integrative modeling using gut Microbiome and exposome data. iScience. 2024;27(3):109294.
Article CAS PubMed PubMed Central Google Scholar
Qiu J, Wu B, Goodman SB, Berry GJ, Goronzy JJ, Weyand CM. Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front Immunol. 2021;12:652771.
Article CAS PubMed PubMed Central Google Scholar
Noto CN, Hoft SG, DiPaolo RJ. Mast cells as important regulators in autoimmunity and cancer development. Front Cell Dev Biol. 2021;9:752350.
Article PubMed PubMed Central Google Scholar
Luo S, Li W, Li Q, Zhang M, Wang X, Wu S, Li Y. Causal effects of gut microbiota on the risk of periodontitis: a two-sample Mendelian randomization study. Front Cell Infect Microbiol. 2023;13:1160993.
Article PubMed PubMed Central Google Scholar
Yang M, Wan X, Zheng H, Xu K, Xie J, Yu H, Wang J, Xu P. No evidence of a genetic causal relationship between ankylosing spondylitis and gut microbiota: a two-sample Mendelian randomization study. Nutrients. 2023;15(4)1057.
Comments (0)